BRIEF published on 07/09/2024 at 09:10, 1 year 4 months ago BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization Drug Development Pharmaceutical Market Master Services Agreement BioNxt Solutions Cladribine ODF
BRIEF published on 07/09/2024 at 09:10, 1 year 4 months ago BioNxt signe un accord-cadre de services avec une organisation internationale de recherche, de développement et de fabrication sous contrat Marché Pharmaceutique Développement De Médicaments Solutions BioNxt Cladribine ODF Contrat-cadre De Services
PRESS RELEASE published on 07/09/2024 at 09:05, 1 year 4 months ago BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization BioNxt Solutions Inc. signs master services agreement with German-based CRDMO for product development of oral dissolvable drug formulations BioNxt Solutions Inc. Product Development Master Services Agreement CRDMO Oral Dissolvable Drug Formulations
BRIEF published on 06/20/2024 at 01:05, 1 year 5 months ago BioNxt Solutions Closes Second Tranche of Private Placement Private Placement Common Shares Warrants Research Funding BioNxt Solutions
BRIEF published on 06/20/2024 at 01:05, 1 year 5 months ago BioNxt Solutions clôture la deuxième tranche de placement privé Placement Privé Actions Ordinaires Bons De Souscription Financement De La Recherche Solutions BioNxt
PRESS RELEASE published on 06/20/2024 at 01:00, 1 year 5 months ago BioNxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placement BioNxt Solutions Inc. closes the second tranche of non-brokered private placement, raising $270,000. Proceeds will fund research, development, and working capital Private Placement Common Shares Working Capital Research And Development BioNxt Solutions Inc.
BRIEF published on 04/26/2024 at 05:55, 1 year 7 months ago BioNxt Solutions Advances Cladribine Studies and Announces Financing Initiative Private Placement BioNxt Solutions Inc. Multiple Sclerosis Cladribine Program Pharmaceutical Development
BRIEF published on 04/26/2024 at 05:55, 1 year 7 months ago BioNxt Solutions fait progresser les études sur la cladribine et annonce une initiative de financement Placement Privé BioNxt Solutions Inc. Sclérose En Plaques Programme Cladribine Développement Pharmaceutique
PRESS RELEASE published on 04/26/2024 at 05:50, 1 year 7 months ago Bionxt Solutions Announces Odf Cladribine Update and Financing BioNxt Solutions Inc. advances Cladribine program to human bioavailability studies in Europe, targeting MS market. Announces private placement for research and development Private Placement BioNxt Solutions Inc. Cladribine Program Bioavailability Studies Multiple Sclerosis Market
BRIEF published on 03/18/2024 at 08:10, 1 year 8 months ago BioNxt Advances Towards Human Trials with ODF Cladribine for MS Clinical Trials BioNxt Solutions Inc. Multiple Sclerosis Drug Delivery Technology Pharmaceutical Market
Published on 12/06/2025 at 00:25, 29 minutes ago GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 54 minutes ago Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 1 hour 24 minutes ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 21:45, 3 hours 9 minutes ago When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 22:15, 2 hours 38 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 2 hours 41 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 5 hours 55 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 6 hours 38 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 1 hour 54 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 54 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 54 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 1 hour 54 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 7 hours 36 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
